CM
Christopher M Starr sold $659K of MNPR stock
Christopher M Starr, Dir of Monopar Therapeutics (MNPR), sold 8,400 shares of MNPR stock worth $659K, per an SEC Form 4 filed Oct 5, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 1, 2026, 4 days before it was made public.
MNPR has moved -9.3% since the trade date, from $77.97 to $70.75 (Nov 18, 2026 close).
- Traded
- Oct 1, 2026
- Disclosed
- Oct 5, 2026
- Filing delay
- 4 days
- Price since
- -9.3%
- Role
- Dir
- Source
- SEC Form 4